INCIDENCE AND CLINICAL IMPACT OF STENT FRACTURE AFTER EVEROLIMUS-ELUTING STENT IMPLANTATION  by Kuramitsu, Shoichi et al.
ACC-i2 with TCT
E205
JACC March 27, 2012
Volume 59, Issue 13
INCIDENCE AND CLINICAL IMPACT OF STENT FRACTURE AFTER EVEROLIMUS-ELUTING STENT 
IMPLANTATION
i2 Poster Contributions
McCormick Place South, Hall A
Saturday, March 24, 2012, 9:30 a.m.-Noon
Session Title: DES - Clinical
Abstract Category: 16. PCI - DES (clinical/outcomes)
Presentation Number: 2531-396
Authors: Shoichi Kuramitsu, Masashi Iwabuchi, Takenori Domei, Takuya Haraguchi, Ayumu Nagae, Yoshio Kazuno, Soichiro Enomoto, Toru Mazaki, 
Makoto Hyodo, Yoshimitsu Soga, Katsuhiro Kondo, Shinichi Shirai, Kenji Ando, Koyu Sakai, Yoshitaka Takabatake, Hiroyoshi Yokoi, Fumitoshi Toyota, 
Masakiyo Nobuyoshi, Kokura Memorial Hospital, Kitakyushu, Japan, Chidoribashi Hospital, Fukuoka, Japan
Background: Stent fracture has currently become an important concern after drug-eluting stent (DES) implantation due to its potential 
association with in-stent restenosis and stent thrombosis. Recent clinical trials have demonstrated improved safety and efficacy of everolimus-
eluting stent (EES). However, the incidence of stent fracture with EES has never been elucidated. The aim of this study was to assess the incidence 
and clinical impact of stent fracture after EES implantation.
Methods: From February 2010 and January 2011, a total of 971 patients with 1218 lesions were treated solely with EES. Among 971 patients, 808 
patients with 1011 lesions (83.0%) underwent follow-up angiography 6 to 9 months after index procedure. Stent fracture was defined as a complete 
or partial separation of the stent on plain fluoroscopy, and/or intravascular ultrasound at follow-up. We assessed the major adverse cardiac events 
(MACE) at 9-months defined as cardiac death, myocardial infarction, and target lesion revascularization (TLR) in patients with and without stent 
fracture.
Results: Stent fracture was observed in 30 patients of 31 lesions (3.0%). The rate of in-stent restenosis and TLR were significantly higher in 
stent fracture lesions than in non-stent fracture lesions (91.4% versus 6.4%, p < 0.001; 85.2% versus 5.2%, p<0.001, respectively). MACE rate at 
9-months in patients with stent fracture was significantly higher than those without stent fracture (74.2% versus 5.6%, p<0.001).
Conclusions: Stent fracture after EES implantation is rare, whereas it is associated with high incidence of TLR.
